The effect of menopausal hormone therapy on melanoma and keratinocyte skin cancer risk: a systematic review and meta-analysis of observational studies

Maturitas ◽  
2021 ◽  
Vol 152 ◽  
pp. 73
Author(s):  
Konstantinos Lallas ◽  
Patroklos Theocharis ◽  
Eirini Boureka ◽  
Efstratios Vakirlis ◽  
Athanasios Kyrgidis ◽  
...  
Keyword(s):  
Systematic Review ◽  
Skin Cancer ◽  
Cancer Risk ◽  
Hormone Therapy ◽  
Observational Studies ◽  
Meta Analysis ◽  
Menopausal Hormone Therapy ◽  
Skin Cancer Risk

scholarly journals A systematic review and meta-analysis of effects of menopausal hormone therapy on cardiovascular diseases

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Ji-Eun Kim ◽  
Jae-Hyuck Chang ◽  
Min-Ji Jeong ◽  
Jaesung Choi ◽  
JooYong Park ◽  
...  
Keyword(s):  
Systematic Review ◽  
Hormone Therapy ◽  
Observational Studies ◽  
Meta Analysis ◽  
Cochrane Review ◽  
Underlying Disease ◽  
Menopausal Hormone Therapy ◽  
Clinical Effects ◽  
Increased Risk ◽  
Timing Of Initiation

AbstractA systematic review and meta-analysis of randomized controlled trials (RCTs) and observational studies was conducted to assess the association between menopausal hormone therapy and cardiovascular disease. The PubMed and EMBASE databases were searched for articles published from 2000 to 2019, using review methods based on a previous Cochrane review. Quality assessment of RCTs and observational studies was conducted using the Jadad scale and the Newcastle–Ottawa Scale, respectively. A total of 26 RCTs and 47 observational studies were identified. The study populations in the RCTs were older and had more underlying diseases than those in the observational studies. Increased risks of venous thromboembolism [summary estimate (SE), 95% confidence interval (CI): RCTs, 1.70, 1.33–2.16; observational studies, 1.32, 1.13–1.54] were consistently identified in both study types, whereas an increased risk of stroke in RCTs (SE: 1.14, 95% CI: 1.04–1.25) and a decreased risk of myocardial infarction in observational studies (SE: 0.79, 95% CI: 0.75–0.84) were observed. Differential clinical effects depending on timing of initiation, underlying disease, regimen type, and route of administration were identified through subgroup analyses. These findings suggest that underlying disease and timing of initiation should be carefully considered before starting therapy in postmenopausal women.

scholarly journals Systemic sclerosis (scleroderma) and cancer risk: systematic review and meta-analysis of observational studies

Rheumatology ◽  
2012 ◽  
Vol 52 (1) ◽  
pp. 143-154 ◽  
Author(s):  
M. Bonifazi ◽  
I. Tramacere ◽  
G. Pomponio ◽  
B. Gabrielli ◽  
E. V. Avvedimento ◽  
...  
Keyword(s):  
Systematic Review ◽  
Systemic Sclerosis ◽  
Cancer Risk ◽  
Observational Studies ◽  
Meta Analysis

scholarly journals Milk and Dairy Product Consumption and Bladder Cancer Risk: A Systematic Review and Meta-Analysis of Observational Studies

2019 ◽  
Vol 10 (suppl_2) ◽  
pp. S224-S238 ◽  
Author(s):  
Laura M Bermejo ◽  
Bricia López-Plaza ◽  
Cristina Santurino ◽  
Iván Cavero-Redondo ◽  
Carmen Gómez-Candela
Keyword(s):  
Systematic Review ◽  
Bladder Cancer ◽  
Cancer Risk ◽  
Observational Studies ◽  
Meta Analysis ◽  
Dairy Product ◽  
Bladder Cancer Risk ◽  
Product Consumption ◽  
Dairy Product Consumption
Sign in / Sign up

Export Citation Format

Share Document